Is a complete ETR/26CA research report available?

No complete published report is available for etr/26CA (ETR/26CA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

ETR/26CA (ETR/26CA)

Deutsche Börse Xetra: ETR/26CA · EUR

€5.85

-0.30 (-4.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-29 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ETR/26CA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	6.4B
Revenue (ttm)	122.3M
Net income (ttm)	-741.1M
EPS (ttm)	-€0.77
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 122.3M
Net income (ttm): -741.1M
EPS (ttm): -€0.77
Market cap: 6.4B

All ETR/26CA indicators

Market & fundamental data

Available fields

138

Groups with data

Currency

USD

Showing 138 of 138 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	691
Employees Change	11%
Employees Change Percent	1.62
Enterprise value	EUR 7.1B
Exchange	Deutsche Börse Xetra
Financial currency	USD
First seen	2026-07-12
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-07-29
Market cap	EUR 6.4B
Price	EUR 5.85
Price currency	EUR
Rev Per Employee	177,717.08x
Sic	2836
Symbol	etr/26CA
Website	https://immunitybio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.52%
EV/Sales	57.21x
FCF yield	-4.03%
P/B ratio	-8.54x
P/S ratio	52.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-185.41%
EBITDA Margin	-174.08%
Gross margin	99.34%
Gross Profit	EUR 121.5M
Gross Profit Growth	349.38%
Gross Profit Growth Q	167.14%
Gross Profit Growth3 Y	520.57%
Gross Profit Growth5 Y	199.72%
Net Income	EUR -741.1M
Pretax Margin	-606.12%
Profit Per Employee	EUR -1.1M
ROA	-34.38
Roa5y	-49.39
ROCE	-45.17
ROIC	-67.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue Growth	351.53x
Revenue Growth Q	167.64x
Revenue Growth3 Y	521.94x
Revenue Growth5 Y	200.12x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.3
Assets	EUR 560.8M
Cash	EUR 330.3M
Current Assets	EUR 398.4M
Current Liabilities	EUR 59.8M
Debt	EUR 975.4M
Debt FCF	EUR -3.76
Equity	EUR -753.8M
Interest Coverage	-2.33
Liabilities	EUR 1.3B
Long Term Assets	EUR 162.4M
Long Term Liabilities	EUR 1.3B
Net Cash	EUR -645M
Net Cash By Market Cap	EUR -10.02
Tangible Book Value	EUR -765.7M
Tangible Book Value Per Share	EUR -0.73

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.67
Inventory Turnover	0.21
Net Working Capital	EUR 11M
Quick ratio	6.24
Working Capital	EUR 333.9M
Working Capital Turnover	EUR 0.55

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-29.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
All Time High	8.35
All Time High Change	-26.35%
All Time High Date	2026-07-02
All Time Low	5.79
All Time Low Change	6.22%
All Time Low Date	2026-06-17
ATR	0.24
High	6.15
High52	8.35
High52 Date	2026-07-02
High52ch	-29.94%
Low	5.85
Low52	5.79
Low52 Date	2026-06-17
Low52ch	1.04%
RSI	36.85
RSI Monthly	0
RSI Weekly	0
Sharpe ratio	-0.06x
Sortino ratio	0
Total Return	-29.76%
Tr1m	-9.02%
Tr1w	-9.29%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -226.7M
Operating margin	-185.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	394,156,849%
Net Borrowing	66,766,980.1
Shares Insiders	28.23%
Shares Institutions	17.8%
Shares Qo Q	3.76%
Shares Yo Y	29.76%
Short Ratio	10.63

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -290M
Adjusted OCF	-286,062,426
Average Volume	4,045.8x
Bv Per Share	-0.72
CAPEX	EUR -3.9M
Ch1m	-9.02
Ch1w	-9.29
Change	-4.88%
Change From Open	-4.88
Close	6.15
Days Gap	0
Depreciation Amortization	14,052,873
Earnings Date	2026-08-07
EBIT	EUR -226.7M
EBITDA	EUR -212.8M
EPS	EUR -0.77
F Score	3
FCF	EUR -259.2M
FCF EV Yield	-3.66x
Financing CF	542,191,728
Fiscal Year End	December
Goodwill	800,457.8
Income Tax	EUR 93,668
Investing CF	-160,953,534
Is Primary Listing	0
Last Report Date	2026-03-31
Ma20	7.15
Ma20ch	-14%
Net CF	126,041,240
Next Earnings Date	2026-08-07
Open	6.15
Position In Range	0
Ppne	128,491,075.8
Price Date	2026-07-28
Relative Volume	0.09x
Revenue	122,269,352x
SBC By Revenue	25.14x
Share Based Comp	30,737,979
Tax By Revenue	0.08x
Volume	0
Z Score	-8.48

ETR/26CA (ETR/26CA)

Coverage state: Market snapshot only — no published research

Generate the first ETR/26CA analysis

Price

Financial snapshot

Fair-value bridge

Latest news · ETR/26CA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ETR/26CA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ETR/26CA

Frequently asked questions